Jesús Martin-Garcia
Amministratore Delegato presso GENEURO SA
Profilo
Jesús Martin-Garcia is the founder of LeShop SA (1996) and GeNeuro SA (Switzerland) (2006), where he holds the title of Chairman & Chief Executive Officer.
Mr. Martin-Garcia is also the founder of Eclosion Foundation.
He currently holds the position of Chairman at GeNeuro SA, Association Des Industries Genevoises Des Sciences De La Vie, and Director at Calliditas Therapeutics Suisse SA, Union des Associations Patronales Genevoises, Harvard Business School Health Industry Alumni Association, DePGen SA, and Managing Partner at Eclosion2 SA. Mr. Martin-Garcia's former positions include Chairman at Value Management Group LLC and ArisGen SA, Managing Director at Eclosion2 & Cie Scpc, Director at Calliditas Therapeutics France SAS (2017-2020), Director at Melcure SA, Principal at McKinsey & Co., Inc. and Forum Mondial de L'Economie, and Engagement Manager at Mckinsey & Co., Inc. (Switzerland).
Mr. Martin-Garcia's education includes undergraduate and graduate degrees from the University of Geneva and an MBA from Harvard Business School.
Posizioni attive di Jesús Martin-Garcia
| Società | Posizione | Inizio |
|---|---|---|
| GENEURO SA | Amministratore Delegato | 01/01/2006 |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Direttore/Membro del Consiglio | - |
Eclosion2 SA
 Eclosion2 SA Financial ConglomeratesFinance Eclosion2 SA provides financial services. | Corporate Officer/Principal | - |
| Association Des Industries Genevoises Des Sciences De La Vie | Presidente | - |
| DePGen SA | Direttore/Membro del Consiglio | - |
| Harvard Business School Health Industry Alumni Association | Direttore/Membro del Consiglio | - |
GeNeuro SA
 GeNeuro SA BiotechnologyHealth Technology Part of GeNeuro SA (Switzerland), the French company develops and manufactures therapeutic products. The company is based in Lyon, France. | Presidente | 26/05/2011 |
| Union des Associations Patronales Genevoises | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Jesús Martin-Garcia
| Società | Posizione | Fine |
|---|---|---|
| GENKYOTEX SA. | Direttore/Membro del Consiglio | 03/11/2020 |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░ | ░░░░░░░░░ | - |
| ░░░░░░░ ░░ | ░░░░░░░░░░ | - |
Formazione di Jesús Martin-Garcia
| Harvard Business School | Masters Business Admin |
| University of Geneva | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GENEURO SA | Health Technology |
| Aziende private | 17 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Forum Mondial de L'Economie
 Forum Mondial de L'Economie Miscellaneous Commercial ServicesCommercial Services Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland. | Commercial Services |
LeShop SA
 LeShop SA Food RetailRetail Trade Part of Migros Group, LeShop SA is an online grocery service. The company is based in Chavannes-de-Bogis, Switzerland. The Swiss company was founded by Jesús Martin-Garcia. LeShop was acquired by Migros-Genossenschafts-Bund from ShoppingNet Holding SA on April 05, 2006. | Retail Trade |
GeNeuro SA
GeNeuro SA BiotechnologyHealth Technology Part of GeNeuro SA (Switzerland), the French company develops and manufactures therapeutic products. The company is based in Lyon, France. | Health Technology |
ArisGen SA
 ArisGen SA Pharmaceuticals: MajorHealth Technology ArisGen SA manufactures novel products. The private company is based in Plan-les-Ouates, Switzerland. The CEO of the Swiss company is Andrew Parker. | Health Technology |
| Mckinsey & Co., Inc. (Switzerland) | |
Eclosion Foundation
 Eclosion Foundation Investment Trusts/Mutual FundsMiscellaneous Eclosion Foundation offers researchers managerial and scientific support for their projects, from finance to validation resources. The firm also provides premises, laboratories, and services adapted to the needs of their clients. It focuses on biotechnology and biomedical engineering sectors. The company was founded by Jesús Martin-Garcia and Benoit Dubois and is headquartered in Plan-les-Ouates, Switzerland. | Miscellaneous |
| Harvard Business School Health Industry Alumni Association | |
Eclosion2 SA
Eclosion2 SA Financial ConglomeratesFinance Eclosion2 SA provides financial services. | Finance |
| Eclosion2 & Cie Scpc | |
| DePGen SA | |
Calliditas Therapeutics France SAS
 Calliditas Therapeutics France SAS Pharmaceuticals: MajorHealth Technology Calliditas Therapeutics France SAS is a biopharmaceutical company, which engages in the NOX therapies. Its therapeutic approach is based on a selective inhibition of NOX enzymes that amplify multiple disease processes, such as fibrosis, inflammation, pain processing, cancer development, and eurodegeneration. The firm’s platform enables the identification of orally available small molecules that selectively inhibit specific NOX enzymes. The company was founded in 2006 and is headquartered in Saint-Julien-en-Genevois, France. | Health Technology |
| Melcure SA | |
| Association Des Industries Genevoises Des Sciences De La Vie | |
Value Management Group LLC
 Value Management Group LLC Miscellaneous Commercial ServicesCommercial Services Value Management Group LLC engages in the provision of healthcare valuation and advisory services. It offers physician compensation valuation and value-based arrangements, real estate appraisal, capital asset appraisal, financial due diligence, litigation and dispute resolution, compensation plan design and consulting, and other healthcare transaction advisory. The company was founded by Greg Koonsman in 1995 and is headquartered in Dallas, TX. | Commercial Services |
| Union des Associations Patronales Genevoises |
- Borsa valori
- Insiders
- Jesús Martin-Garcia
